Clinical trial
Prospective Monitoring of Immune Parameters in Patients With Hepatitis C Under Treatment With Direct Acting Antivirals
NCT02904603 is registered in ClinicalTrials.gov with University of Regensburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Monitoring of Immune Parameters in Patients With Hepatitis C Under Treatment With Direct Acting Antivirals
- Lead sponsor
- University of Regensburg
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- January 31, 2017
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.